PDB Short entry for 3CP9 HEADER TRANSFERASE 31-MAR-08 3CP9 TITLE CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A TITLE 2 PYRIDONE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: PROTEIN KINASE DOMAIN, RESIDUES 940-989 DELETED; COMPND 5 SYNONYM: VEGFR-2, KINASE INSERT DOMAIN RECEPTOR, PROTEIN-TYROSINE COMPND 6 KINASE RECEPTOR FLK-1, CD309 ANTIGEN; COMPND 7 EC: 2.7.10.1; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: KDR, FLK1; SOURCE 6 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7111; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS RECEPTOR TYROSINE KINASE, ANGIOGENESIS, ATP-BINDING, DEVELOPMENTAL KEYWDS 2 PROTEIN, DIFFERENTIATION, GLYCOPROTEIN, HOST-VIRUS INTERACTION, KEYWDS 3 IMMUNOGLOBULIN DOMAIN, MEMBRANE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, KEYWDS 4 POLYMORPHISM, TRANSFERASE, TRANSMEMBRANE, TYROSINE-PROTEIN KINASE EXPDTA X-RAY DIFFRACTION AUTHOR D.A.WHITTINGTON,A.M.LONG,P.ROSE,Y.GU,H.ZHAO REVDAT 6 21-FEB-24 3CP9 1 REMARK REVDAT 5 20-OCT-21 3CP9 1 REMARK SEQADV REVDAT 4 13-JUN-18 3CP9 1 SOURCE DBREF SEQADV REVDAT 3 26-JUL-17 3CP9 1 SOURCE REVDAT 2 24-FEB-09 3CP9 1 VERSN REVDAT 1 17-JUN-08 3CP9 0 JRNL AUTH E.HU,A.TASKER,R.D.WHITE,R.K.KUNZ,J.HUMAN,N.CHEN,R.BURLI, JRNL AUTH 2 R.HUNGATE,P.NOVAK,A.ITANO,X.ZHANG,V.YU,Y.NGUYEN,Y.TUDOR, JRNL AUTH 3 M.PLANT,S.FLYNN,Y.XU,K.L.MEAGHER,D.A.WHITTINGTON,G.Y.NG JRNL TITL DISCOVERY OF ARYL AMINOQUINAZOLINE PYRIDONES AS POTENT, JRNL TITL 2 SELECTIVE, AND ORALLY EFFICACIOUS INHIBITORS OF RECEPTOR JRNL TITL 3 TYROSINE KINASE C-KIT. JRNL REF J.MED.CHEM. V. 51 3065 2008 JRNL REFN ISSN 0022-2623 JRNL PMID 18447379 JRNL DOI 10.1021/JM800188G REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 10000.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 22848 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.211 REMARK 3 FREE R VALUE : 0.263 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.900 REMARK 3 FREE R VALUE TEST SET COUNT : 1341 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4491 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 60 REMARK 3 SOLVENT ATOMS : 118 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 42.80 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 4.56900 REMARK 3 B22 (A**2) : 4.23800 REMARK 3 B33 (A**2) : -8.80700 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -3.87100 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.30 REMARK 3 ESD FROM SIGMAA (A) : 0.29 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.40 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.37 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.270 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 21.30 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.760 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3CP9 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 01-APR-08. REMARK 100 THE DEPOSITION ID IS D_1000047049. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 31-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9793 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MAR CCD 165 MM REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22862 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 4.100 REMARK 200 R MERGE (I) : 0.09300 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 15.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.59 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 4.10 REMARK 200 R MERGE FOR SHELL (I) : 0.49400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.25 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.29 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 5000 MME, HEPES, AMMONIUM SULFATE, REMARK 280 SODIUM CHLORIDE, ISOPROPANOL, BETA-MERCAPTOETHANOL , PH 8.0, REMARK 280 VAPOR DIFFUSION, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 33.58500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU A 815 REMARK 465 HIS A 816 REMARK 465 GLY A 841 REMARK 465 ARG A 842 REMARK 465 GLY A 843 REMARK 465 ALA A 844 REMARK 465 PHE A 845 REMARK 465 GLY A 846 REMARK 465 LEU A 1049 REMARK 465 ALA A 1050 REMARK 465 ARG A 1051 REMARK 465 ASP A 1052 REMARK 465 ILE A 1053 REMARK 465 PTR A 1054 REMARK 465 LYS A 1055 REMARK 465 ASP A 1056 REMARK 465 PRO A 1057 REMARK 465 ASP A 1058 REMARK 465 PTR A 1059 REMARK 465 VAL A 1060 REMARK 465 ARG A 1061 REMARK 465 LYS A 1062 REMARK 465 GLY A 1063 REMARK 465 ASP A 1064 REMARK 465 ALA A 1065 REMARK 465 ARG A 1066 REMARK 465 GLU B 815 REMARK 465 HIS B 816 REMARK 465 ALA B 817 REMARK 465 GLU B 818 REMARK 465 ALA B 844 REMARK 465 PHE B 845 REMARK 465 LYS B 871 REMARK 465 GLU B 872 REMARK 465 GLY B 873 REMARK 465 ALA B 991 REMARK 465 PRO B 992 REMARK 465 GLU B 993 REMARK 465 ASP B 994 REMARK 465 LEU B 995 REMARK 465 TYR B 996 REMARK 465 ALA B 1050 REMARK 465 ARG B 1051 REMARK 465 ASP B 1052 REMARK 465 ILE B 1053 REMARK 465 PTR B 1054 REMARK 465 LYS B 1055 REMARK 465 ASP B 1056 REMARK 465 PRO B 1057 REMARK 465 ASP B 1058 REMARK 465 PTR B 1059 REMARK 465 VAL B 1060 REMARK 465 ARG B 1061 REMARK 465 LYS B 1062 REMARK 465 GLY B 1063 REMARK 465 ASP B 1064 REMARK 465 ALA B 1065 REMARK 465 ARG B 1066 REMARK 465 ALA B 1166 REMARK 465 ASN B 1167 REMARK 465 ALA B 1168 REMARK 465 GLN B 1169 REMARK 465 GLN B 1170 REMARK 465 ASP B 1171 REMARK 465 ARG B 1172 REMARK 465 HIS B 1173 REMARK 465 HIS B 1174 REMARK 465 HIS B 1175 REMARK 465 HIS B 1176 REMARK 465 HIS B 1177 REMARK 465 HIS B 1178 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 871 173.63 -58.88 REMARK 500 ALA A 874 117.98 34.11 REMARK 500 ARG A1027 -9.79 79.09 REMARK 500 ASP A1028 52.27 -152.42 REMARK 500 SER A1037 -163.20 -108.76 REMARK 500 ASP A1112 -154.47 -125.45 REMARK 500 HIS B 895 136.55 -170.03 REMARK 500 ASN B 897 30.36 -98.88 REMARK 500 PRO B 937 -75.92 -57.12 REMARK 500 TYR B 938 173.08 -48.11 REMARK 500 ARG B1027 -15.92 78.52 REMARK 500 ASP B1028 51.60 -152.34 REMARK 500 ASP B1046 105.04 -162.18 REMARK 500 PRO B1068 -27.85 -39.24 REMARK 500 PRO B1105 150.30 -49.90 REMARK 500 ASP B1112 -155.38 -148.44 REMARK 500 LEU B1164 4.42 -64.36 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 TYR1054 AND TYR1059 WERE PHOSPHORYLATED BY AN AUTOPHOSPHORYLATION REMARK 600 REACTION RUN ON THE PROTEIN PRIOR TO CRYSTALLIZATION. THE REMARK 600 PHOSPHORYLATED TYR IS REPRESENTED BY PTR, PHOSPHONOTYROSINE, REMARK 600 PTR1054 AND PTR1059. THESE RESIDUES ARE PART OF THE KINASE REMARK 600 ACTIVATION LOOP AND THEY ARE DISORDERED IN THE STRUCTURE AND REMARK 600 CONSEQUENTLY NOT SEEN IN THE ELECTRON DENSITY. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE C19 A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE C19 B 502 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3CPB RELATED DB: PDB REMARK 900 RELATED ID: 3CPC RELATED DB: PDB DBREF 3CP9 A 815 939 UNP P35968 VGFR2_HUMAN 815 939 DBREF 3CP9 A 990 1171 UNP P35968 VGFR2_HUMAN 990 1171 DBREF 3CP9 B 815 939 UNP P35968 VGFR2_HUMAN 815 939 DBREF 3CP9 B 990 1171 UNP P35968 VGFR2_HUMAN 990 1171 SEQADV 3CP9 ALA A 817 UNP P35968 CYS 817 ENGINEERED MUTATION SEQADV 3CP9 THR A 916 UNP P35968 VAL 916 ENGINEERED MUTATION SEQADV 3CP9 VAL A 990 UNP P35968 GLU 990 ENGINEERED MUTATION SEQADV 3CP9 ARG A 1172 UNP P35968 EXPRESSION TAG SEQADV 3CP9 HIS A 1173 UNP P35968 EXPRESSION TAG SEQADV 3CP9 HIS A 1174 UNP P35968 EXPRESSION TAG SEQADV 3CP9 HIS A 1175 UNP P35968 EXPRESSION TAG SEQADV 3CP9 HIS A 1176 UNP P35968 EXPRESSION TAG SEQADV 3CP9 HIS A 1177 UNP P35968 EXPRESSION TAG SEQADV 3CP9 HIS A 1178 UNP P35968 EXPRESSION TAG SEQADV 3CP9 ALA B 817 UNP P35968 CYS 817 ENGINEERED MUTATION SEQADV 3CP9 THR B 916 UNP P35968 VAL 916 ENGINEERED MUTATION SEQADV 3CP9 VAL B 990 UNP P35968 GLU 990 ENGINEERED MUTATION SEQADV 3CP9 ARG B 1172 UNP P35968 EXPRESSION TAG SEQADV 3CP9 HIS B 1173 UNP P35968 EXPRESSION TAG SEQADV 3CP9 HIS B 1174 UNP P35968 EXPRESSION TAG SEQADV 3CP9 HIS B 1175 UNP P35968 EXPRESSION TAG SEQADV 3CP9 HIS B 1176 UNP P35968 EXPRESSION TAG SEQADV 3CP9 HIS B 1177 UNP P35968 EXPRESSION TAG SEQADV 3CP9 HIS B 1178 UNP P35968 EXPRESSION TAG SEQRES 1 A 314 GLU HIS ALA GLU ARG LEU PRO TYR ASP ALA SER LYS TRP SEQRES 2 A 314 GLU PHE PRO ARG ASP ARG LEU LYS LEU GLY LYS PRO LEU SEQRES 3 A 314 GLY ARG GLY ALA PHE GLY GLN VAL ILE GLU ALA ASP ALA SEQRES 4 A 314 PHE GLY ILE ASP LYS THR ALA THR CYS ARG THR VAL ALA SEQRES 5 A 314 VAL LYS MET LEU LYS GLU GLY ALA THR HIS SER GLU HIS SEQRES 6 A 314 ARG ALA LEU MET SER GLU LEU LYS ILE LEU ILE HIS ILE SEQRES 7 A 314 GLY HIS HIS LEU ASN VAL VAL ASN LEU LEU GLY ALA CYS SEQRES 8 A 314 THR LYS PRO GLY GLY PRO LEU MET VAL ILE THR GLU PHE SEQRES 9 A 314 CYS LYS PHE GLY ASN LEU SER THR TYR LEU ARG SER LYS SEQRES 10 A 314 ARG ASN GLU PHE VAL PRO TYR LYS VAL ALA PRO GLU ASP SEQRES 11 A 314 LEU TYR LYS ASP PHE LEU THR LEU GLU HIS LEU ILE CYS SEQRES 12 A 314 TYR SER PHE GLN VAL ALA LYS GLY MET GLU PHE LEU ALA SEQRES 13 A 314 SER ARG LYS CYS ILE HIS ARG ASP LEU ALA ALA ARG ASN SEQRES 14 A 314 ILE LEU LEU SER GLU LYS ASN VAL VAL LYS ILE CYS ASP SEQRES 15 A 314 PHE GLY LEU ALA ARG ASP ILE PTR LYS ASP PRO ASP PTR SEQRES 16 A 314 VAL ARG LYS GLY ASP ALA ARG LEU PRO LEU LYS TRP MET SEQRES 17 A 314 ALA PRO GLU THR ILE PHE ASP ARG VAL TYR THR ILE GLN SEQRES 18 A 314 SER ASP VAL TRP SER PHE GLY VAL LEU LEU TRP GLU ILE SEQRES 19 A 314 PHE SER LEU GLY ALA SER PRO TYR PRO GLY VAL LYS ILE SEQRES 20 A 314 ASP GLU GLU PHE CYS ARG ARG LEU LYS GLU GLY THR ARG SEQRES 21 A 314 MET ARG ALA PRO ASP TYR THR THR PRO GLU MET TYR GLN SEQRES 22 A 314 THR MET LEU ASP CYS TRP HIS GLY GLU PRO SER GLN ARG SEQRES 23 A 314 PRO THR PHE SER GLU LEU VAL GLU HIS LEU GLY ASN LEU SEQRES 24 A 314 LEU GLN ALA ASN ALA GLN GLN ASP ARG HIS HIS HIS HIS SEQRES 25 A 314 HIS HIS SEQRES 1 B 314 GLU HIS ALA GLU ARG LEU PRO TYR ASP ALA SER LYS TRP SEQRES 2 B 314 GLU PHE PRO ARG ASP ARG LEU LYS LEU GLY LYS PRO LEU SEQRES 3 B 314 GLY ARG GLY ALA PHE GLY GLN VAL ILE GLU ALA ASP ALA SEQRES 4 B 314 PHE GLY ILE ASP LYS THR ALA THR CYS ARG THR VAL ALA SEQRES 5 B 314 VAL LYS MET LEU LYS GLU GLY ALA THR HIS SER GLU HIS SEQRES 6 B 314 ARG ALA LEU MET SER GLU LEU LYS ILE LEU ILE HIS ILE SEQRES 7 B 314 GLY HIS HIS LEU ASN VAL VAL ASN LEU LEU GLY ALA CYS SEQRES 8 B 314 THR LYS PRO GLY GLY PRO LEU MET VAL ILE THR GLU PHE SEQRES 9 B 314 CYS LYS PHE GLY ASN LEU SER THR TYR LEU ARG SER LYS SEQRES 10 B 314 ARG ASN GLU PHE VAL PRO TYR LYS VAL ALA PRO GLU ASP SEQRES 11 B 314 LEU TYR LYS ASP PHE LEU THR LEU GLU HIS LEU ILE CYS SEQRES 12 B 314 TYR SER PHE GLN VAL ALA LYS GLY MET GLU PHE LEU ALA SEQRES 13 B 314 SER ARG LYS CYS ILE HIS ARG ASP LEU ALA ALA ARG ASN SEQRES 14 B 314 ILE LEU LEU SER GLU LYS ASN VAL VAL LYS ILE CYS ASP SEQRES 15 B 314 PHE GLY LEU ALA ARG ASP ILE PTR LYS ASP PRO ASP PTR SEQRES 16 B 314 VAL ARG LYS GLY ASP ALA ARG LEU PRO LEU LYS TRP MET SEQRES 17 B 314 ALA PRO GLU THR ILE PHE ASP ARG VAL TYR THR ILE GLN SEQRES 18 B 314 SER ASP VAL TRP SER PHE GLY VAL LEU LEU TRP GLU ILE SEQRES 19 B 314 PHE SER LEU GLY ALA SER PRO TYR PRO GLY VAL LYS ILE SEQRES 20 B 314 ASP GLU GLU PHE CYS ARG ARG LEU LYS GLU GLY THR ARG SEQRES 21 B 314 MET ARG ALA PRO ASP TYR THR THR PRO GLU MET TYR GLN SEQRES 22 B 314 THR MET LEU ASP CYS TRP HIS GLY GLU PRO SER GLN ARG SEQRES 23 B 314 PRO THR PHE SER GLU LEU VAL GLU HIS LEU GLY ASN LEU SEQRES 24 B 314 LEU GLN ALA ASN ALA GLN GLN ASP ARG HIS HIS HIS HIS SEQRES 25 B 314 HIS HIS HET C19 A 501 30 HET C19 B 502 30 HETNAM C19 3-(2-AMINOQUINAZOLIN-6-YL)-1-(3,3-DIMETHYLINDOLIN-6- HETNAM 2 C19 YL)-4-METHYLPYRIDIN-2(1H)-ONE FORMUL 3 C19 2(C24 H23 N5 O) FORMUL 5 HOH *118(H2 O) HELIX 1 1 ASP A 823 GLU A 828 1 6 HELIX 2 2 PRO A 830 ASP A 832 5 3 HELIX 3 3 THR A 875 GLY A 893 1 19 HELIX 4 4 ASN A 923 SER A 930 1 8 HELIX 5 5 PRO A 992 LYS A 997 5 6 HELIX 6 6 THR A 1001 SER A 1021 1 21 HELIX 7 7 ALA A 1030 ARG A 1032 5 3 HELIX 8 8 GLU A 1038 ASN A 1040 5 3 HELIX 9 9 LEU A 1067 MET A 1072 5 6 HELIX 10 10 ALA A 1073 ARG A 1080 1 8 HELIX 11 11 THR A 1083 PHE A 1099 1 17 HELIX 12 12 ASP A 1112 GLU A 1121 1 10 HELIX 13 13 THR A 1132 TRP A 1143 1 12 HELIX 14 14 GLU A 1146 ARG A 1150 5 5 HELIX 15 15 THR A 1152 HIS A 1178 1 27 HELIX 16 16 ASP B 823 GLU B 828 1 6 HELIX 17 17 PRO B 830 ASP B 832 5 3 HELIX 18 18 THR B 875 GLY B 893 1 19 HELIX 19 19 ASN B 923 SER B 930 1 8 HELIX 20 20 LYS B 931 ASN B 933 5 3 HELIX 21 21 LEU B 1002 ARG B 1022 1 21 HELIX 22 22 ALA B 1030 ARG B 1032 5 3 HELIX 23 23 GLU B 1038 ASN B 1040 5 3 HELIX 24 24 LEU B 1067 MET B 1072 5 6 HELIX 25 25 ALA B 1073 ARG B 1080 1 8 HELIX 26 26 THR B 1083 PHE B 1099 1 17 HELIX 27 27 ASP B 1112 GLU B 1121 1 10 HELIX 28 28 THR B 1132 TRP B 1143 1 12 HELIX 29 29 GLU B 1146 ARG B 1150 5 5 HELIX 30 30 THR B 1152 LEU B 1164 1 13 SHEET 1 A 5 LEU A 834 PRO A 839 0 SHEET 2 A 5 VAL A 848 PHE A 854 -1 O GLU A 850 N GLY A 837 SHEET 3 A 5 CYS A 862 MET A 869 -1 O VAL A 867 N ILE A 849 SHEET 4 A 5 MET A 913 GLU A 917 -1 O VAL A 914 N LYS A 868 SHEET 5 A 5 LEU A 901 CYS A 905 -1 N LEU A 902 O ILE A 915 SHEET 1 B 2 ILE A1034 LEU A1036 0 SHEET 2 B 2 VAL A1042 ILE A1044 -1 O LYS A1043 N LEU A1035 SHEET 1 C 5 LEU B 834 GLY B 841 0 SHEET 2 C 5 GLN B 847 PHE B 854 -1 O VAL B 848 N LEU B 840 SHEET 3 C 5 CYS B 862 MET B 869 -1 O VAL B 865 N ALA B 851 SHEET 4 C 5 MET B 913 GLU B 917 -1 O VAL B 914 N LYS B 868 SHEET 5 C 5 LEU B 901 CYS B 905 -1 N LEU B 902 O ILE B 915 SHEET 1 D 2 PHE B 935 VAL B 936 0 SHEET 2 D 2 LEU B1000 THR B1001 1 O LEU B1000 N VAL B 936 SHEET 1 E 2 ILE B1034 LEU B1036 0 SHEET 2 E 2 VAL B1042 ILE B1044 -1 O LYS B1043 N LEU B1035 CISPEP 1 ALA A 991 PRO A 992 0 -0.17 SITE 1 AC1 13 LEU A 840 ALA A 866 LYS A 868 GLU A 885 SITE 2 AC1 13 LEU A 889 THR A 916 GLU A 917 CYS A 919 SITE 3 AC1 13 LEU A1035 ILE A1044 CYS A1045 ASP A1046 SITE 4 AC1 13 PHE A1047 SITE 1 AC2 11 ALA B 866 LYS B 868 GLU B 885 LEU B 889 SITE 2 AC2 11 THR B 916 GLU B 917 CYS B 919 HIS B1026 SITE 3 AC2 11 LEU B1035 CYS B1045 ASP B1046 CRYST1 55.570 67.170 89.102 90.00 93.08 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017995 0.000000 0.000967 0.00000 SCALE2 0.000000 0.014888 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011239 0.00000